International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics

References

• PackerSEthics and medical patentsArch Ophthalmol1999117824610369598
   PubMedGoogle Scholar
• KottowMHPatenting medical proceduresArch Ophthalmol2000118114010922218
   PubMedGoogle Scholar
• EllweinLBKrollPNarinFLinkage between research sponsorship and patented eye-care technologyInvest Ophthalmol Vis Sci19963724955038933766
   PubMed Web of Science ®Google Scholar
• NovackGDThe role of pharmaceutical companies in sponsored researchOphthalmology20071141037817544773
   PubMed Web of Science ®Google Scholar
• ClarkABingamanDKapinMOcular angiostatic agentsExp Opin Ther Patents20001042748
   Web of Science ®Google Scholar
• De WitDLightmanSEmerging approaches to the treatment of uveitis: patents of 2000–2004Exp Opin Ther Patents20051586174
   Web of Science ®Google Scholar
• JanoriaKGHariharanSDasariCRRecent patents and advances in ophthalmic drug deliveryRecent Patents on Drug Delivery and Formulations2007116170
   PubMedGoogle Scholar
• SallamAJajakumarSLightmanSIntraocular delivery of anti-infective drugs-bacterial, viral, fungal and parasiticRecent Patents Anti-Infect Drug Disc200835363
   Google Scholar
• ConwayBRRecent patents on ocular drug delivery systemsRecent Patents on Drug Delivery and Formulations2008218
   Google Scholar
• GurtlerFGurnyRPatent literature review of ophthalmic insertsDrug Dev Industrial Pharmacy199521118
   Web of Science ®Google Scholar
• MuckeHAMNew ocular therapeutics: a view from the patenting perspectiveIDrugs200710374117187313
   PubMed Web of Science ®Google Scholar
• PATENTSCOPE(R) Search Service[www.wipo.int/pctdb/]GenevaWorld Intellectual Property Organization
   Google Scholar
• Medical Subject Headings[http://www.nlm.nih.gov/mesh/]BethesdaNational Library of Medicine – National Institutes of Health
   Google Scholar
• DombAFrucht-PeryJShapiroMinventorsHadasit Medical Research Services and Development Co. Ltd. and Yissum Research Development Co of the Hebrew University of Jerusalem, assigneesA device for iontophoretic administration of drugsPCT patent application WO 99/40967. 1999 Aug 19.
   Google Scholar
• Eljarrat-BinstockERaiskupFFrucht-PeryJHydrogel probe for iontophoresis drug delivery to the eyeJ Biomater Sci Polym Ed20041539741315212325
   PubMed Web of Science ®Google Scholar
• LloydLBParkinsonTMSzlekMinventorsIomed, Inc., assigneeOcular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the samePCT patent application WO 02/058786. 2002 Aug 1.
   Google Scholar
• ParkinsonTMSzlekMLloydLBinventorsIomed, Inc., assigneeOcular iontophoretic device and method of usePCT patent application WO 02/058789. 2002 Aug 1.
   Google Scholar
• WarrenSHamiltonSinventorsIomed, Inc., assigneeMethods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicamentsPCT patent application WO 03/007961. 2003 Jan 30.
   Google Scholar
• ParkinsonTMSzlekMLloydLBinventorsIomed, Inc., assigneeOcular iontophoretic device and method for using the samePCT patent application WO 03/008036. 2003 Jan 30.
   Google Scholar
• ParkinsonTMFergusonEFebbraroSTolerance of ocular iontophoresis in healthy volunteersJ Ocul Pharmacol Ther2003191455112804059
   PubMed Web of Science ®Google Scholar
• LamTTEdwardDPZhuXATransscleral iontophoresis of dexamethasoneArch Ophthalmol198910736871
   Google Scholar
• Eljarrat-BinstockEDombAJOrucovFMethotrexate delivery to the eye using transscleral hydrogel iontophoresisCurr Eye Res2007327–86394617852187
   PubMed Web of Science ®Google Scholar
• BerdugoMValamaneshFAndrieuCDelivery of antisense oligonucleotide to the cornea by iontophoresisAntisense Nucleic Acid Drug Dev2003131071412804037
   PubMedGoogle Scholar
• De BizemontTSennlaubFBehar-CohenFinventorsOptis France S.A.Institut National de la Sante et de la Recherche Medicale (INSERM), assigneesGene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresisPCT patent application WO 02/083184. 2002 Oct 21
   Google Scholar
• BeharFRoyPinventorsOptis France S.A. assigneeDevice for delivering medicines by transpalpebral electrophoresisPCT patent application WO 03/030989. 2003 Apr 17.
   Google Scholar
• BeharFRoyPinventorsOptis France S.A. assigneeDevice for medicine delivery by intraocular iontophoresis or electroporationPCT patent application WO 03/043689. 2003 May 30.
   Google Scholar
• RoyPKleinsingerAinventorsOptis France S.A. assigneeOcular device for current controlled variable delivery of active principlesPCT patent application WO 2004/105864. 2004 Dec 9.
   Google Scholar
• RoyPinventorOptis France S.A. assigneeIrritation-reducing ocular iontophoretic devicePCT patent application WO 2005/115281. 2005 Dec 8.
   Google Scholar
• RoyPinventorEyegate Pharma S.A. assigneeOcular iontophoresis device for delivering siRNA and aptamersPCT patent application WO 2006/072887. 2006 Jul 13
   Google Scholar
• RoyPinventorEyegate Pharma S.A. assigneeOcular iontophoresis devicePCT patent application WO 2007/099406. 2007 Sep 7.
   Google Scholar
• HiguchiWIMillerDJLiKSinventorsAciont, Inc., assigneeMethods and systems for controlling and/or increasing iontophoretic fluxPCT patent application WO 2004/077012. 2004 Sep 10.
   Google Scholar
• HiguchiJKochambilliRTuitupouAinventorsAciont, Inc. assigneeOcular administration of immunosuppressive agentsPCT patent application WO 2007/038687. 2007 Apr 5.
   Google Scholar
• HiguchiJWLiKSinventorsAciont, Inc., assigneeIntraocular iontophoretic device and associated methodsPCT patent application WO 2007/050645. 2007 May 3
   Google Scholar
• LiKSHiguchiJWinventorsAciont, Inc., assigneeMethod and device for minimally invasive site specific ocular drug deliveryPCT patent application WO 2008/013913. 2008 Jan 31.
   Google Scholar
• LiSKZhangYZhuHInfluence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transportJ Pharm Sci2005948476015736190
   PubMed Web of Science ®Google Scholar
• MolokhiaSAJeongEKHiguchiWIExamination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imagingInt J Pharm20073351–2465317236728
   PubMed Web of Science ®Google Scholar
• JoshiAVinventorCeramatec Inc., assigneeNovel iontophoretic drug delivery systemsPCT patent application WO 03/039622. 2003 May 15.
   Google Scholar
• HellerRJaroszeskiMJGilbertRAinventorsUniversity of South Florida, assigneeElectroporation device and method for delivery to ocular tissuePCT patent application WO 2005/123183. 2005 Dec 29.
   Google Scholar
• LecanuLPapadopoulosVCutting-edge patents in Alzheimer’s disease drug discovery: anticipation of potential future treatmentsRecent Patents CNS Drug Discov2007211322
   PubMedGoogle Scholar